Compliance filing under SEBI Regulation 74(5) for Sep 2026 quarter

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.8%Reaction day

₹0.79

prior close

—

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+2.5% vs market

Plastic Products - Industrial peers, median of 44sector+0.0%+3.8% vs sector

On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 3.8 pts more than its Plastic Products - Industrial peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.8+1.3+2.5+0.0+3.8

Next day

+3.8+1.1+2.7-0.2+4.0

+0.0-1.7+1.7-1.2+1.2

+1.3-1.5+2.7-2.0+3.3

-1.3-0.6-0.7-1.7+0.5

+1.3-0.4+1.7-2.0+3.2

+8.9-1.4+10.2-1.9+10.7

15d

+3.8pendingpending-5.2+9.0

—————

UpDownMarket · Nifty Microcap 250Sector · Plastic Products - Industrial peers, median of 44Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Amerise Biosciences submitted a certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The Registrar and Share Transfer Agent, Satellite Corporate Services, confirmed that no physical share certificates were received for dematerialization during the quarter. This is a routine regulatory compliance submission to BSE.

Likely market impact

Routine compliance filing; no material impact on shareholders or stock price.